Baird Medical Investment Holdings Limited
BDMD
$3.20
$0.113.56%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.95M | 11.95M | 6.57M | 6.57M | 9.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.95M | 11.95M | 6.57M | 6.57M | 9.96M |
| Cost of Revenue | 1.37M | 1.37M | 822.80K | 822.80K | 1.09M |
| Gross Profit | 10.58M | 10.58M | 5.75M | 5.75M | 8.86M |
| SG&A Expenses | 3.40M | 3.40M | 2.19M | 2.19M | 3.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.84M | 6.84M | 4.02M | 4.02M | 5.52M |
| Operating Income | 5.11M | 5.11M | 2.54M | 2.54M | 4.43M |
| Income Before Tax | 4.62M | 4.62M | 2.43M | 2.43M | 4.71M |
| Income Tax Expenses | 504.00K | 504.00K | 240.60K | 240.60K | 559.50K |
| Earnings from Continuing Operations | 4.11M | 4.11M | 2.19M | 2.19M | 4.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -49.90K | -49.90K | -22.40K | -22.40K | -43.80K |
| Net Income | 4.06M | 4.06M | 2.17M | 2.17M | 4.11M |
| EBIT | 5.11M | 5.11M | 2.54M | 2.54M | 4.43M |
| EBITDA | 5.39M | 5.39M | 2.84M | 2.84M | 4.74M |
| EPS Basic | 0.19 | 0.19 | 0.07 | 0.07 | 0.19 |
| Normalized Basic EPS | 0.13 | 0.13 | 0.05 | 0.05 | 0.13 |
| EPS Diluted | 0.19 | 0.19 | 0.07 | 0.07 | 0.19 |
| Normalized Diluted EPS | 0.13 | 0.13 | 0.05 | 0.05 | 0.13 |
| Average Basic Shares Outstanding | 21.70M | 21.70M | 29.41M | 29.41M | 21.70M |
| Average Diluted Shares Outstanding | 21.84M | 21.84M | 29.41M | 29.41M | 21.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |